Figure 1.
Predicted Risk of Sepsis and SREs as a function of lenalidomide persistence – 1 year follow-up.

Predicted Risk of Sepsis and SREs as a function of lenalidomide persistence – 1 year follow-up.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal